7 min. read

Omada price tag guesses. Pear’s telemed Rx.

PLUS: Anti-Kickback reform and DTx

Issue 079

 E&O Fridays.

Welcome back. Last Friday I broke some news: Amwell has held talks to acquire Omada Health. (Omada counts Sanofi as an investor, so I found

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Recent Articles